Charles Erlichman
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Pathology and Forensic Medicine top 0.5%
Papers in
- Oncology 178
- Colorectal Cancer Treatments and Studies 63
- Cancer Treatment and Pharmacology 55
- Lung Cancer Research Studies 22
-
- Lung Cancer Treatments and Mutations 31
- Co-authors
- Shai FineAlex A. AdjeiHenry C. PitotScott H. KaufmannMatthew M. AmesT ElhakimJoel PicusMichelle R. Mahoney
- Journals
- Journal of Clinical Oncology (85 papers)Cancer Chemotherapy and Pharmacology (18 papers)Investigational New Drugs (18 papers)Clinical Cancer Research (12 papers)Cancer Research (12 papers)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Charles Erlichman
309 papers receiving 11.7k citations
Peers
Comparison fields: 5 of 142
- Oncology 6.0k
- Pathology and Forensic Medicine 1.8k
- Cancer Research 1.3k
- Molecular Biology 5.2k
- Hepatology 576
Countries citing papers authored by Charles Erlichman
This map shows the geographic impact of Charles Erlichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Erlichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Erlichman more than expected).
Fields of papers citing papers by Charles Erlichman
This network shows the impact of papers produced by Charles Erlichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Erlichman. The network helps show where Charles Erlichman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Erlichman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 5 | |
| 3 | 2016 | 62 | |
| 4 | 2014 | 96 | |
| 5 | 2011 | 42 | |
| 6 | 2011 | 16 | |
| 7 | 2009 | 43 | |
| 8 | 2009 | 263 | |
| 9 | Abstract #3602: Ongoing phase 1 study of a novel PARP inhibitor, ABT-888 in combination with temozolamide; Pharmacokinetics, safety and anti-tumor activity | 2009 | 2 |
| 10 | 2008 | 41 | |
| 11 | 2008 | 57 | |
| 12 | 2006 | 109 | |
| 13 | 2005 | 6 | |
| 14 | 2005 | 16 | |
| 15 | BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines | 2005 | 2 |
| 16 | Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. | 2001 | 87 |
| 17 | Comparison of potential markers of farnesyltransferase inhibition. | 2000 | 103 |
| 18 | A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. | 2000 | 201 |
| 19 | Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials. | 1998 | 14 |
| 20 | Treatment of primary hepatocellular carcinoma by hepatic arterial infusion of 4'-epirubicin | 1990 | 1 |
About Charles Erlichman
Charles Erlichman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Hematology and Pathology and Forensic Medicine, having authored 313 papers that have together received 12.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (63 papers), Cancer Treatment and Pharmacology (55 papers), Cancer therapeutics and mechanisms (42 papers), Lung Cancer Treatments and Mutations (31 papers), PI3K/AKT/mTOR signaling in cancer (26 papers), Chronic Lymphocytic Leukemia Research (22 papers), Heat shock proteins research (22 papers) and Lung Cancer Research Studies (22 papers). The work is most often cited by research in Oncology (6.0k citations), Pathology and Forensic Medicine (1.8k citations), Cancer Research (1.3k citations), Molecular Biology (5.2k citations) and Hepatology (576 citations). Charles Erlichman has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Shai Fine, Alex A. Adjei, Henry C. Pitot, Scott H. Kaufmann, Matthew M. Ames, T Elhakim, Joel Picus, Michelle R. Mahoney, Tom R. Fitch and A. Wong. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.